In concordance with our AML cell line data, Tet2/Stag2-mutant bone marrow cells exhibited higher levels of dsDNA breaks and increased sensitivity to treatment with talazoparib when cultured in vitro (Supplemental Figure 3, E–G). Here, STAG2 is linked to acute myeloid leukemia.